Table 2.
miR-34a expression in thyroid lesions and clinical characteristics
| Clinical characteristics | Patients (n) | miR34a expression (mean ± SD) | P |
|---|---|---|---|
| Age (years) | |||
| ≤45 | 41 | 0.3495 ± 0.02 | 0.2729 |
| >45 | 34 | 0.3759 ± 0.01 | |
| Gender | |||
| Male | 43 | 0.3551± 0.02 | 0.5398 |
| Female | 32 | 0.3700 ± 0.02 | |
| Tumor stage | |||
| I/II | 47 | 0.4111 ± 0.01 | <0.0001 |
| III/IV | 18 | 0.2811 ± 0.02 | |
| Histopathology | |||
| PTC | 41 | 0.4251 ± 0.08 | <0.0001 |
| FTC | 12 | 0.3217 ± 0.04 | |
| MTC | 8 | 0.3050 ± 0.05 | |
| ATC | 4 | 0.2650 ± 0.05 | |
| Goiter | 10 | 0.1980 ± 0.03 | |
| Lesion numbers | |||
| Single | 51 | 0.3629 ± 0.02 | 0.4865 |
| Multiple | 24 | 0.3442 ± 0.02 | |
| Location | |||
| Left | 38 | 0.3597 ± 0.11 | 0.8570 |
| Right | 26 | 0.3600 ± 0.11 | |
| Both | 11 | 0.3400 ± 0.12 | |
| SUVmax | <0.0001 | ||
| Low (≤3.63) | 27 | 0.4326 ± 0.02 | |
| High (>3.63) | 48 | 0.3098 ± 0.01 |
Abbreviations: SD, standard deviation; PTC; papillary thyroid carcinoma; FTC, follicular thyroid carcinoma; MTC, medullary thyroid carcinoma; ATC, anaplastic thyroid carcinoma; SUVmax, maximum standardized uptake value.